Literature DB >> 18036345

Osteoactivin fragments produced by ectodomain shedding induce MMP-3 expression via ERK pathway in mouse NIH-3T3 fibroblasts.

Harumi Furochi1, Seiko Tamura, Mai Mameoka, Chiharu Yamada, Takayuki Ogawa, Katsuya Hirasaka, Yuushi Okumura, Takahito Imagawa, Sachiko Oguri, Kazumi Ishidoh, Kyoichi Kishi, Shigeki Higashiyama, Takeshi Nikawa.   

Abstract

Intact osteoactivin, a novel type I membrane glycoprotein, were shed at a dibasic motif in the juxtamembrane region in C2C12 myoblasts. Extracellular fragments were secreted into the culture media by a putative metalloprotease. Extracellular fragments of osteoactivin, but not control protein, induced matrix metalloprotease-3 (MMP-3) expression in NIH-3T3 fibroblasts. Epidermal growth factor (ERK) kinase inhibitors inhibited the osteoactivin-mediated MMP-3 expression, whereas the extracellular fragment of osteoactivin activated ERK1/2 and p38 in the mitogen-activated protein kinase pathway. Our results suggest that the extracellular fragments of osteoactivin produced by shedding act as a growth factor to induce MMP-3 expression via the ERK pathway in fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18036345     DOI: 10.1016/j.febslet.2007.11.036

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  35 in total

1.  The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair.

Authors:  Bing Li; Ana P Castano; Thomas E Hudson; Brian T Nowlin; Shuei-Liong Lin; Joseph V Bonventre; Kenneth D Swanson; Jeremy S Duffield
Journal:  FASEB J       Date:  2010-08-13       Impact factor: 5.191

Review 2.  Molecular and cellular mechanisms of ectodomain shedding.

Authors:  Kazutaka Hayashida; Allison H Bartlett; Ye Chen; Pyong Woo Park
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

3.  Induction of matrix metalloproteinase-3 (MMP-3) expression in the microglia by lipopolysaccharide (LPS) via upregulation of glycoprotein nonmetastatic melanoma B (GPNMB) expression.

Authors:  Fangyuan Shi; Shuangyan Duan; Jihong Cui; Xingrong Yan; Hongmin Li; Yingjuan Wang; Fulin Chen; Lihua Zhang; Jun Liu; Xin Xie
Journal:  J Mol Neurosci       Date:  2014-03-30       Impact factor: 3.444

4.  Differential expression of glycoprotein non-metastatic melanoma protein B (GPNMB) involved in trichostatin A-induced apoptosis in gastric cancer.

Authors:  Wei-Min Ruan; Yun-Long Li; Gang Nie; Wen-Xue Zhou; Xiao-Ming Zou
Journal:  Int J Clin Exp Med       Date:  2014-12-15

5.  Matrix metalloprotease-3 and tissue inhibitor of metalloprotease-1 mRNA and protein levels are altered in response to traumatic skeletal muscle injury.

Authors:  Maria L Urso; Eric R Szelenyi; Gordon L Warren; Brian R Barnes
Journal:  Eur J Appl Physiol       Date:  2010-03-27       Impact factor: 3.078

6.  The PKD domain distinguishes the trafficking and amyloidogenic properties of the pigment cell protein PMEL and its homologue GPNMB.

Authors:  Alexander C Theos; Brenda Watt; Dawn C Harper; Karolina J Janczura; Sarah C Theos; Kathryn E Herman; Michael S Marks
Journal:  Pigment Cell Melanoma Res       Date:  2013-04-02       Impact factor: 4.693

7.  Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease.

Authors:  Vagishwari Murugesan; Jun Liu; Ruhua Yang; Haiquin Lin; Andrew Lischuk; Gregory Pastores; Xiaokui Zhang; Wei-Lien Chuang; Pramod K Mistry
Journal:  Blood Cells Mol Dis       Date:  2016-12-13       Impact factor: 3.039

Review 8.  Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  FASEB J       Date:  2020-05-23       Impact factor: 5.191

9.  Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein.

Authors:  Toshihiko Hoashi; Shinichi Sato; Yuji Yamaguchi; Thierry Passeron; Kunihiko Tamaki; Vincent J Hearing
Journal:  FASEB J       Date:  2010-01-07       Impact factor: 5.191

10.  ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties.

Authors:  April A N Rose; Matthew G Annis; Zhifeng Dong; Francois Pepin; Michael Hallett; Morag Park; Peter M Siegel
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.